352 related articles for article (PubMed ID: 21685263)
1. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
Vessey DA; Li L; Kelley M
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
[TBL] [Abstract][Full Text] [Related]
2. Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning.
Vessey DA; Li L; Kelley M
J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):190-5. PubMed ID: 20200324
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
Vessey DA; Li L; Honbo N; Karliner JS
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
[TBL] [Abstract][Full Text] [Related]
4. Ischemic preconditioning requires opening of pannexin-1/P2X(7) channels not only during preconditioning but again after index ischemia at full reperfusion.
Vessey DA; Li L; Kelley M
Mol Cell Biochem; 2011 May; 351(1-2):77-84. PubMed ID: 21267638
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
7. Importance of timing of magnesium administration in the isolated ischemic-reperfused rat heart: role of K(ATP) channels.
Bazargan M; Faghihi M; Chitsaz M
Physiol Res; 2008; 57(6):839-846. PubMed ID: 18052684
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of P2Y2 and P2X7 purinergic receptors in the isolated rat heart mediates ischemia-reperfusion injury.
Granado M; Amor S; Montoya JJ; Monge L; Fernández N; García-Villalón ÁL
Vascul Pharmacol; 2015 Oct; 73():96-103. PubMed ID: 26070527
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Zhong B; Wang DH
Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
[TBL] [Abstract][Full Text] [Related]
10. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
11. Adenosine triphosphate postconditioning is associated with better preserved global and regional cardiac function during myocardial ischemia and reperfusion: a speckle tracking imaging-based echocardiologic study.
Ren M; Liu Y; Zhao H; Dong S; Jiang Z; Li K; Tian J
Cardiovasc Ther; 2016 Oct; 34(5):343-51. PubMed ID: 27328167
[TBL] [Abstract][Full Text] [Related]
12. Treatment of rats with hypolipidemic compound pirinixic acid protects their hearts against ischemic injury: are mitochondrial K(ATP) channels and reactive oxygen species involved?
Nemčeková M; Čarnická S; Ferko M; Muráriková M; Ledvényiová V; Ravingerová T
Physiol Res; 2013; 62(5):577-84. PubMed ID: 24020817
[TBL] [Abstract][Full Text] [Related]
13. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
14. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning.
Vessey DA; Kelley M; Li L; Huang Y
Oxid Med Cell Longev; 2009; 2(3):146-51. PubMed ID: 20592769
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
[TBL] [Abstract][Full Text] [Related]
18. Role of pannexin and adenosine triphosphate (ATP) following myocardial ischemia/reperfusion.
Kristiansen SB; Skovsted GF; Berchtold LA; Radziwon-Balicka A; Dreisig K; Edvinsson L; Sheykhzade M; Haanes KA
Scand Cardiovasc J; 2018 Dec; 52(6):340-343. PubMed ID: 30481075
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Dexmedetomidine Postconditioning in the Field of Myocardial Ischemia-Reperfusion Injury.
Bunte S; Behmenburg F; Majewski N; Stroethoff M; Raupach A; Mathes A; Heinen A; Hollmann MW; Huhn R
Anesth Analg; 2020 Jan; 130(1):90-98. PubMed ID: 31633505
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
